PGP9.5 Monoclonal Antibody, PE-Cy5.5 Conjugated, Clone: [11G10], PE/Cy5.5, Mouse

Artikelnummer: BSS-BSM-41257M-PE-CY5.5
Artikelname: PGP9.5 Monoclonal Antibody, PE-Cy5.5 Conjugated, Clone: [11G10], PE/Cy5.5, Mouse
Artikelnummer: BSS-BSM-41257M-PE-CY5.5
Hersteller Artikelnummer: bsm-41257M-PE-Cy5.5
Alternativnummer: BSS-BSM-41257M-PE-CY5.5-100
Hersteller: Bioss
Wirt: Mouse
Kategorie: Antikörper
Applikation: WB
Spezies Reaktivität: Human, Mouse, Rat
Konjugation: PE/Cy5.5
Alternative Synonym: Gracile axonal dystrophy, Neuron cytoplasmic protein 9.5, Park 5, Park5, Parkinson Disease 5, PGP 9.5, PGP9.5, PGP95, Protein gene product 9.5, Ubiquitin C terminal esterase L1, Ubiquitin C terminal hydrolase (neuron specific), Ubiquitin C terminal hydrolase, Ubiquitin carboxyl terminal esterase L1, Ubiquitin carboxyl terminal hydrolase isozyme L1, Ubiquitin carboxyl-terminal hydrolase isozyme L1, Ubiquitin thioesterase L1, Ubiquitin thiolesterase, Ubiquitin thiolesterase L1, UCH L1, UCH-L1, UCHL1, UCHL1_HUMAN.
The protein encoded by this gene belongs to the peptidase C12 family. This enzyme is a thiol protease that hydrolyzes a peptide bond at the C-terminal glycine of ubiquitin. This gene is specifically expressed in the neurons and in cells of the diffuse neuroendocrine system. Mutations in this gene may be associated with Parkinson disease.[provided by RefSeq, Sep 2009]
Klonalität: Monoclonal
Konzentration: 1ug/ul
Klon-Bezeichnung: [11G10]
NCBI: 7345
UniProt: P09936
Puffer: Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Quelle: Recombinant human UCHL1 protein
Target-Kategorie: PGP9.5
Application Verdünnung: WB(1:300-5000)